Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)
Close on Nov 17, 2026Market cap $2.57BP/E –Yield –
Xencor operating margin
Operating margin is operating income as a percentage of revenue.
Xencor's operating margin for the twelve months ending Jun 30, 2026 was -205.8%. For fiscal 2025 it was -141.4%, against -161.5% the year before. The highest annual figure on record is 40.4% in fiscal 2016.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -141.4% | +20.1 |
| FY2024 | Dec 31, 2024 | -161.5% | −85.7 |
| FY2023 | Dec 31, 2023 | -75.8% | −25.7 |
| FY2022 | Dec 31, 2022 | -50.1% | −66.0 |
| FY2021 | Dec 31, 2021 | 15.9% | +78.5 |
| FY2020 | Dec 31, 2020 | -62.6% | −71.4 |
| FY2019 | Dec 31, 2019 | 8.8% | +204.3 |
| FY2018 | Dec 31, 2018 | -195.5% | −102.0 |
| FY2017 | Dec 31, 2017 | -93.4% | −133.8 |
| FY2016 | Dec 31, 2016 | 40.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -72.4% | +3.7 |
| Q1 FY2026 | Mar 31, 2026 | -1724.1% | −1592.2 |
| Q4 FY2025 | Dec 31, 2025 | -189.9% | −165.0 |
| Q3 FY2025 | Sep 30, 2025 | -226.3% | +83.9 |
| Q2 FY2025 | Jun 30, 2025 | -76.1% | +155.5 |
| Q1 FY2025 | Mar 31, 2025 | -131.9% | +209.8 |
| Q4 FY2024 | Dec 31, 2024 | -25.0% | +28.7 |
| Q3 FY2024 | Sep 30, 2024 | -310.2% | −279.3 |
| Q2 FY2024 | Jun 30, 2024 | -231.6% | −174.5 |
| Q1 FY2024 | Mar 31, 2024 | -341.7% | −21.4 |
| Q4 FY2023 | Dec 31, 2023 | -53.7% | +143.4 |
| Q3 FY2023 | Sep 30, 2023 | -30.9% | +109.6 |
| Q2 FY2023 | Jun 30, 2023 | -57.1% | +35.7 |
| Q1 FY2023 | Mar 31, 2023 | -320.3% | −351.3 |
| Q4 FY2022 | Dec 31, 2022 | -197.1% | −256.6 |
| Q3 FY2022 | Sep 30, 2022 | -140.5% | +69.4 |
| Q2 FY2022 | Jun 30, 2022 | -92.8% | −106.3 |
| Q1 FY2022 | Mar 31, 2022 | 31.0% | +77.1 |
| Q4 FY2021 | Dec 31, 2021 | 59.5% | +92.2 |
| Q3 FY2021 | Sep 30, 2021 | -209.8% | −162.5 |
| Q2 FY2021 | Jun 30, 2021 | 13.5% | +300.7 |
| Q1 FY2021 | Mar 31, 2021 | -46.1% | −19.0 |
| Q4 FY2020 | Dec 31, 2020 | -32.7% | +836.8 |
| Q3 FY2020 | Sep 30, 2020 | -47.3% | +18.3 |
| Q2 FY2020 | Jun 30, 2020 | -287.3% | −186.8 |
| Q1 FY2020 | Mar 31, 2020 | -27.1% | −97.0 |
| Q4 FY2019 | Dec 31, 2019 | -869.5% | −687.2 |
| Q3 FY2019 | Sep 30, 2019 | -65.6% | −67.8 |
| Q2 FY2019 | Jun 30, 2019 | -100.4% | −118.1 |
| Q1 FY2019 | Mar 31, 2019 | 69.9% | +138.0 |
| Q4 FY2018 | Dec 31, 2018 | -182.3% | +285.1 |
| Q3 FY2018 | Sep 30, 2018 | 2.2% | – |
| Q4 FY2017 | Dec 31, 2017 | 17.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -68.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -467.4% | – |
See a number that looks wrong?